Suppr超能文献

黄酮类化合物的新治疗方面:黄芩及其主要活性成分汉黄芩素、黄芩素和黄芩苷的抗癌特性。

New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin.

作者信息

Li-Weber Min

机构信息

Tumor Immunology Program D030, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

出版信息

Cancer Treat Rev. 2009 Feb;35(1):57-68. doi: 10.1016/j.ctrv.2008.09.005. Epub 2008 Nov 11.

Abstract

Traditional Chinese medicines have been recently recognized as a new source of anticancer drugs and new chemotherapy adjuvant to enhance the efficacy of chemotherapy and to ameliorate the side effects of cancer chemotherapies however their healing mechanisms are still largely unknown. Scutellaria baicalensis is one of the most popular and multi-purpose herb used in China traditionally for treatment of inflammation, hypertension, cardiovascular diseases, and bacterial and viral infections. Accumulating evidence demonstrate that Scutellaria also possesses potent anticancer activities. The bioactive components of Scutellaria have been confirmed to be flavones. The major constituents of Scutellaria baicalensis are Wogonin, Baicalein and Baicalin. These phytochemicals are not only cytostatic but also cytotoxic to various human tumor cell lines in vitro and inhibit tumor growth in vivo. Most importantly, they show almost no or minor toxicity to normal epithelial and normal peripheral blood and myeloid cells. The antitumor functions of these flavones are largely due to their abilities to scavenge oxidative radicals, to attenuate NF-kappaB activity, to inhibit several genes important for regulation of the cell cycle, to suppress COX-2 gene expression and to prevent viral infections. The tumor-selectivity of Wogonin has recently been demonstrated to be due to its ability to differentially modulate the oxidation-reduction status of malignant vs. normal lymphocytic cells and to preferentially induce phospholipase C gamma 1, a key enzyme involved in Ca(2+) signaling, through H(2)O(2) signaling in malignant lymphocytes. This review is aimed to summarize the research results obtained since the last 20 years and to highlight the recently discovered molecular mechanisms.

摘要

中药最近已被公认为抗癌药物的新来源以及新的化疗辅助药物,可增强化疗效果并减轻癌症化疗的副作用,然而其治疗机制在很大程度上仍不为人知。黄芩是中国传统上最常用且用途广泛的草药之一,用于治疗炎症、高血压、心血管疾病以及细菌和病毒感染。越来越多的证据表明,黄芩还具有强大的抗癌活性。黄芩的生物活性成分已被确认为黄酮类化合物。黄芩的主要成分是汉黄芩素、黄芩素和黄芩苷。这些植物化学物质在体外对各种人类肿瘤细胞系不仅具有细胞抑制作用,还具有细胞毒性,并且在体内可抑制肿瘤生长。最重要的是,它们对正常上皮细胞、正常外周血和骨髓细胞几乎没有毒性或毒性很小。这些黄酮类化合物的抗肿瘤功能很大程度上归因于它们清除氧化自由基、减弱核因子-κB活性、抑制几个对细胞周期调控很重要的基因、抑制COX-2基因表达以及预防病毒感染的能力。最近已证明汉黄芩素的肿瘤选择性是由于其能够差异调节恶性与正常淋巴细胞的氧化还原状态,并通过恶性淋巴细胞中的H(2)O(2)信号优先诱导参与Ca(2+)信号传导的关键酶磷脂酶Cγ1。这篇综述旨在总结过去20年以来获得的研究结果,并突出最近发现的分子机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验